16.88

2.37% 0.39

Palatin Technologies Inc. (PTN)

Overview News Price History Option Chain Discussions Forecast Stock Split

Palatin Technologies Inc. stock is traded at $16.88, with a volume of 21,502. It is up +2.37% in the last 24 hours and up +14.91% over the past month. Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Its drug development programs also include melanocortin receptor system program, such as PL-8177, a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, a preclinical development candidate for treating ocular inflammation, as well as melanocortin receptor 4 peptides and orally-active small molecules to treat genetic metabolic and obesity disorders. In addition, the company develops natriuretic peptide receptor systems comprising PL3994, a natriuretic peptide receptor-A agonist, which has completed Phase I clinical study for the treatment of cardiovascular indications; and PL-5028, a dual natriuretic peptide receptor A and C agonist that is in preclinical development for cardiovascular diseases, such as reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.

Previous Close:

$16.49

Open:

$16.87

24h Volume:

21,502

Relative Volume:

0.05

Market Cap:

$28.74M

Revenue:

$7.10M

Net Income/Loss:

$-31.59M

P/E Ratio:

-6.4674

EPS:

-2.61

Net Cash Flow:

$-26.75M

1W Performance:

+5.17%

1M Performance:

+14.91%

6M Performance:

+17,838%

1Y Performance:

+1,606%

1-Day Range:

$16.27

$16.88

1-Week Range:

$15.45

$17.74

52-Week Range:

$0.0866

$31.00

Palatin Technologies Inc. Stock (PTN) Company Profile

Name

Palatin Technologies Inc.

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

609-495-2200

Address

Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ

Employee

Twitter

@PalatinTech

Next Earnings Date

2024-11-12

Latest SEC Filings

PTN's Discussions on Twitter

Compare PTN vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PTN Palatin Technologies Inc.	16.88	28.08M	7.10M	-31.59M	-26.75M	-2.61
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-12-25	Initiated	Laidlaw	Buy
Dec-03-25	Initiated	Alliance Global Partners	Buy
Jun-05-15	Reiterated	Canaccord Genuity	Buy
Jan-12-15	Reiterated	ROTH Capital	Buy
May-23-12	Initiated	Noble Financial	Buy
Jan-23-07	Initiated	Next Generation	Buy

View All

Palatin Technologies Inc. Stock (PTN) Latest News

Feb 08, 2026

Head-To-Head Contrast: Palatin Technologies (PINK:PTNT) vs. Akorn (OTCMKTS:AKRXQ) - Defense World

Feb 08, 2026

Jan 26, 2026

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & Palatin Technologies (PINK:PTNT) Critical Analysis - Defense World

Jan 26, 2026

Jan 20, 2026

Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals - MSN

Jan 20, 2026

The Truth About Palatin Technologies (PTN): Tiny Biotech, Huge Hype – But Is It Worth Your Money? - AD HOC NEWS

Jan 20, 2026

Jan 15, 2026

Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World

Jan 15, 2026

Jan 12, 2026

Palatin Technologies Targets Hypothalamic Obesity as Next Frontier Beyond GLP-1s (NYSE: PTN) - TradingView — Track All Markets

Jan 12, 2026

Jan 08, 2026

Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now - MSN

Jan 08, 2026

Jan 07, 2026

Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World

Jan 07, 2026

Jan 05, 2026

Palatin Technologies (PTNT) Stock Forecast and Price Target 2026 - MarketBeat

Jan 05, 2026

Jan 02, 2026

Palatin Technologies (PTN) officer reports Form 4 tax-withheld shares - Stock Titan

Jan 02, 2026

Palatin Technologies (PTN) CEO Carl Spana details tax share withholdings - Stock Titan

Jan 02, 2026

Palatin finishes phase 2 trial in obesity treatment study - MSN

Jan 02, 2026

Dec 30, 2025

Palatin Technologies (PINK:PTNT) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World

Dec 30, 2025

Dec 29, 2025

Palatin Technologies (PTN) CFO/COO reports 565-share insider stock sale - Stock Titan

Dec 29, 2025

PTN (PTN) holder plans Rule 144 sale of 565 common shares - Stock Titan

Dec 29, 2025

Dec 26, 2025

Comparing Clever Leaves (NASDAQ:CLVR) and Palatin Technologies (PINK:PTNT) - Defense World

Dec 26, 2025

Dec 21, 2025

Palatin Technologies, Inc.(NYSEAM: PTN) added to S&P TMI Index - marketscreener.com

Dec 21, 2025

Dec 20, 2025

Decliners Report: How Palatin Technologies Inc. (PTN) stock reacts to new regulationsEarnings Miss & Long Hold Capital Preservation Tips - Улправда

Dec 20, 2025

Palatin Technologies Earnings Notes - Trefis

Dec 20, 2025

Dec 18, 2025

How Palatin Technologies Inc. (PTN) stock reacts to new regulationsTrade Risk Assessment & Capital Efficiency Focused Strategies - Улправда

Dec 18, 2025

Dec 17, 2025

Palatin Technologies Inc trading resumes - MSN

Dec 17, 2025

Dec 16, 2025

Palatin Technologies (PINK:PTNT) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World

Dec 16, 2025

Dec 15, 2025

Why Is Palatin Technologies, Inc. (PTN) Stock Up Today? - Meyka

Dec 15, 2025

Laidlaw Begins Coverage on Palatin Technologies (NYSEAMERICAN:PTN) - Defense World

Dec 15, 2025

Dec 12, 2025

JANUS HENDERSON GROUP PLC Acquires Shares in Palatin Technologies Inc - GuruFocus

Dec 12, 2025

Palatin Techs (PTN) Receives 'Buy' Rating from Laidlaw & Co. | P - GuruFocus

Dec 12, 2025

Laidlaw initiates coverage on Palatin Technologies stock with Buy rating By Investing.com - Investing.com Australia

Dec 12, 2025

Laidlaw initiates coverage on Palatin Technologies stock with Buy rating - Investing.com

Dec 12, 2025

Dec 11, 2025

Palatin Technologies (PTN) executive Wills records vested RSUs and options - Stock Titan

Dec 11, 2025

Palatin Technologies (PTN) director awarded new 2011 Plan stock options - Stock Titan

Dec 11, 2025

Palatin Technologies (PTN) CEO logs RSU vesting and option awards after 18‑month performance period - Stock Titan

Dec 11, 2025

[Form 4] PALATIN TECHNOLOGIES INC Insider Trading Activity - Stock Titan

Dec 11, 2025

Why Are Palatin Technologies (PTN) Shares Spiking After-Hours? - Benzinga

Dec 11, 2025

Dec 10, 2025

Critical Survey: NexImmune (NASDAQ:NEXI) and Palatin Technologies (PINK:PTNT) - Defense World

Dec 10, 2025

Dec 08, 2025

Palatin Technologies (PTN): Janus Henderson reports 9.99% beneficial ownership stake - Stock Titan

Dec 08, 2025

Dec 06, 2025

Palatin Technologies (PINK:PTNT) Stock Crosses Above Two Hundred Day Moving Average – Should You Sell? - Defense World

Dec 06, 2025

Dec 05, 2025

Can Palatin Technologies Inc. (PTN) stock attract ESG investmentsMarket Performance Recap & Safe Entry Momentum Tips - Newser

Dec 05, 2025

Dec 04, 2025

Why analysts raise outlook for Palatin Technologies Inc. (PTN) stockMarket Growth Review & Weekly Watchlist for Hot Stocks - Newser

Dec 04, 2025

Is Palatin Technologies Inc. (PTN) stock overpriced at current multiplesQuarterly Trade Summary & Real-Time Sentiment Analysis - Newser

Dec 04, 2025

Dec 03, 2025